Agios Pharmaceuticals Inc. (AGIO)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q4  2021
Lee Ainslie - Maverick Capital Sell 100.00% 26,960 0.01
Q3  2021
Lee Ainslie - Maverick Capital Buy 26,960 0.01
Q2  2021
Lee Ainslie - Maverick Capital Sell 100.00% 4,042 0.00
Q1  2021
Lee Ainslie - Maverick Capital Add 1270.17% 3,747 0.00
Q4  2020
Lee Ainslie - Maverick Capital Buy 295 0.00
Q4  2019
Meridian Contrarian Fund Sell 100.00% 62,000 0.38
Q2  2019
Meridian Contrarian Fund Reduce 54.07% 73,000 0.67
Q4  2018
Meridian Contrarian Fund Add 18.42% 21,000 0.19
Q2  2018
Meridian Contrarian Fund Reduce 13.64% 18,000 0.24
Leon Cooperman Sell 100.00% 45,000 0.14
Q1  2018
Leon Cooperman Buy 45,000 0.14
Meridian Contrarian Fund Reduce 3.65% 5,000 0.07
Q3  2017
Meridian Contrarian Fund Add 9.60% 12,000 0.14
Q1  2017
Meridian Contrarian Fund Add 100.00% 62,500 0.70
Q4  2016
Meridian Contrarian Fund Reduce 26.04% 22,000 0.18
Q2  2016
Meridian Contrarian Fund Add 42.02% 25,000 0.21
Q4  2015
Meridian Contrarian Fund Buy 59,500 0.71

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.